INTERNATIONAL PATENT: GUARDANT HEALTH, INC. FILES APPLICATION FOR "TUMOR FRACTION AND OUTCOME ASSOCIATION IN A REAL-WORLD NON-SMALL CELL LUNG CANCER (NSCLC) COHORT USING A METHYLATION-BASED CIRCULATING TUMOR DNA (CTDNA) ASSAY"

GENEVA, May 28 -- GUARDANT HEALTH, INC. (3100 Hanover StreetPalo Alto, California 94304) filed a patent application (PCT/US2024/056153) for "TUMOR FRACTION AND OUTCOME ASSOCIATION IN A REAL-WORLD NON-SMALL CELL LUNG CANCER (NSCLC) COHORT USING A METHYLATION-BASED CIRCULATING TUMOR DNA (CTDNA) ASSAY" on Nov 15, 2024. With publication no. WO/2025/106837, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GORDON, Sean (3100 Hanover StreetPalo Alto, California 94304)

Abstract: Provided herein are methods of determining a mole...